Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Epix Pharmaceuticals, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Epix Pharmaceuticals, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Epix Pharmaceuticals, Inc. since 2005.
The reporting company's ticker symbol is EPIX. The reporting company's CIK number is 1027702.
The total value of stock buying since 2005 is $0.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $104,068.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2009-02-25||Drapkin Kimberlee C (Chief Financial Officer)||Option Ex||8,750||.00||0|
|2009-02-25||Schor Chen (Chief Business Officer)||Option Ex||8,750||.00||0|
|2007-01-03||Kauffman Michael G (Chief Executive Officer)||Option Ex||50,521||.98||49,510|
|2006-11-28||Schor Chen (Chief Business Officer)||Option Ex||3,000||.98||2,940|
|2006-11-06||Drapkin Kimberlee C (Chief Financial Officer)||Option Ex||11,000||.98||10,780|
|2006-11-03||Kauffman Michael G (Chief Executive Officer)||Option Ex||26,672||.98||26,138|
|2006-11-02||Schor Chen (Chief Business Officer)||Option Ex||15,000||.98||14,700|
Insider trading activities including stock purchases, stock sales, and option exercises of EPIX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Epix Pharmaceuticals, Inc. (symbol EPIX, CIK number 1027702) see the Securities and Exchange Commission (SEC) website.